Are you a new member? Sign up now
Login area
| Sign up
close
DACOGEN - 50mg - 1
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01BC08 | B | Decitabine - 50mg | 6497 | 167159/10 | DACOGEN | 50mg | 1 | Injectable lyophilised powder for solution | Infusion | Mersaco | BSP Pharmaceuticals SpA | Italy | 84,497,096 L.L | 2.44 | E2 | Janssen Pharmaceutica NV | Belgium | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01BC08 | B | Decitabine - 50mg | 11542 | 33923/1 | DACOGEN | 50mg | 1 | Injectable lyophilised powder for solution | Infusion | Mersaco | BSP Pharmaceuticals SpA | Italy | 84,497,096 L.L | 2.44 | E2 | Janssen Cilag International NV | Belgium | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024